Who benefits when parents administer intravenous antibiotics, at home, to children with cystic fibrosis? A critical review.

QR Code

Who benefits when parents administer intravenous antibiotics, at home, to children with cystic fibrosis? A critical review.

Introduction: Cystic fibrosis (C.F.) is the most prevalent hereditary life-limiting disorder in the United Kingdom (Cystic Fibrosis Trust, 2008). Contemporary social policy states that, whenever possible, young people are best cared for at home(Department of Health, 2003; Department of Health, 2004...

Full description

Bibliographic Details
Main Author:	Walsh, Daniel
Format:	Dissertation (University of Nottingham only)
Language:	English
Published:	2009
Online Access:	https://eprints.nottingham.ac.uk/23370/

Similar Items

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Association of Antibiotics, Airway Microbiome and Inflammation in Infants with Cystic Fibrosis.
by: Pittman, J., et al.
Published: (2017)

Parent’s stories of the lived experience of parenting a child with Cystic Fibrosis
by: Downing, Hannah
Published: (2013)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Cystic fibrosis diagnosis: Impact on mothers of affected Australian children
by: Priddis, Lynn, et al.
Published: (2009)

Administration of Home Intravenous Chemotherapy to Children by their Parents: Parentsâ€™ Evaluation of a Nationwide Program
by: McCall, C., et al.
Published: (2017)

Corrective effects on airway epithelial function by human amniotic epithelial cells (HAEC) when treating cystic fibrosis
by: Kicic, Anthony, et al.
Published: (2015)

Comparison of tiletamine-zolazepam and tiletamine-zolazepam-ketamine-xylazine administered intravenously in dogs
by: Chen, Hui Cheng, et al.
Published: (2005)

Effect of dehydration on the pharmacokinetics of oxytetracycline hydrochloride administered intravenously in goats (Capra hircus)
by: Elsheikh, Hatim Ali, et al.
Published: (1998)

Disposition kinetics of tylosin administered intravenously and intramuscularly in Desert Sheep and Nubian Goats
by: Taha, A.A., et al.
Published: (1999)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

METABOLOMIC RESPONSE OF HEALTHY AND CYSTIC FIBROSIS EPITHELIUM TO RHINOVIRUS
by: Agudelo-Romero, P., et al.
Published: (2019)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)

Respiratory viral infections in Western Australians with cystic fibrosis
by: Brestovac, Brian, et al.
Published: (2020)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Impact of lung disease on respiratory impedance in young children with cystic fibrosis
by: Ramsey, K., et al.
Published: (2015)

Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis
by: Ramsey, K., et al.
Published: (2014)

Novel end points for clinical trials in young children with cystic fibrosis
by: Simpson, S., et al.
Published: (2013)

Early detection of lung function abnormalities in young children with cystic fibrosis
by: Gangell, C., et al.
Published: (2012)

IL-1 IS ASSOCIATED WITH STRUCTURAL LUNG DISEASE IN CHILDREN WITH CYSTIC FIBROSIS
by: Montgomery, S.T., et al.
Published: (2018)

Airway surface liquid pH is not acidic in children with cystic fibrosis
by: Schultz, A., et al.
Published: (2017)

The association between Staphylococcus aureus and subsequent bronchiectasis in children with cystic fibrosis
by: Caudri, D., et al.
Published: (2018)

Homing and engraftment of intravenously administered equine cord blood-derived multipotent mesenchymal stromal cells to surgically created cutaneous wound in horses: a pilot project
by: Mund, Suzanne J. K., et al.
Published: (2020)

What issues need to be considered by nurses when faced with parents who refuse treatment for their children? A Critical Review
by: Donnison, Rachel
Published: (2008)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

sTREM-1 is elevated in cystic fibrosis and correlates with proteases
by: Forrester, D.L., et al.
Published: (2017)